The objective of this project is to develop a nanotechnology platform that can simultaneously be used to diagnose and treat Alzheimer’s. The work will explore how to develop multifunctional nanocarriers that contain both an imaging agent and a therpeutic agent and also will improve the binding capabilities of the nanocarrier allowing regulation of the release of therapeutic molecules to amyloid lesions.
Biomarkers/Diagnostics/Studies of Risk & Resilience, Foundational
Ananth Annapragada, Ph.D
Jason Eriksen, Ph.D.
Christoph Lange, | 2023
Lars Bertram, Christina M. Lill, | 2023
Xianlin Han, Bernard Fongang, Juan Pablo Palavicini, Tiffany F. Kautz, | 2023
Mathias Jucker, Stefan Lichtenthaler, Stephan Kaeser, | 2022
P. Murali Doraiswamy, | 2020
Andrew S. Yoo, | 2021
Brain Donor Project, | 2021
Christina M. Lill, Lars Bertram, | 2020